Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.
External link for Cipla
Lower Parel
Ganpatrao Kadam Marg,
Mumbai, Maharashtra 400013, IN
Mumbai Central
Mumbai, Maharashtra 400008, IN
Mispel St
Bellville, Western Cape 7530, ZA
Cipla reposted this
Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts In an exclusive interview with #IndiaPharmaOutlook, Jaideep Gogtay, Global Chief Medical Officer at Cipla, discusses how pharmaceutical companies in India are adjusting their R&D strategies to address antimicrobial resistance (AMR). Have a Look Here: https://qrcd.org/7gVL #AddressingAntimicrobialResistance #RandDstrategies #pharmaceuticaldevelopment #antibioticdevelopment
Cipla reposted this
MD & Global CEO | Patient Centricity I Transformation I Innovation I Digital Health | Governance
Extremely proud to have Cipla continue to feature in this prestigious list with improved ESG scores each time. A recognition of our deep-seated commitment to grow sustainably while also caring for our patients, people, and the planet. #CaringForLife #ESG #Sustainability #DJSI
Cipla is honoured to be included in the prestigious Dow Jones Sustainability Indices (DJSI) World Index and the DJSI Emerging Markets Index for 2024. We achieved an impressive third place globally in the Drug and Pharmaceutical sector, with an ESG score of 79, up from 70 last year. This recognition underscores Cipla's steadfast commitment to sustainable growth, value creation for all stakeholders, and contributions towards a greener future. A heartfelt thank you to all our employees, partners, stakeholders, and communities for their unwavering support in reaching this milestone. Together, we are making a significant impact.
Cipla shines at the 3rd Edition of IHW Patient First Awards 2024. - Spirofy initiative in Nepal bags Gold in the Patient-Centric Pharmaceutical Company in Pulmonology category for advancing respiratory health & improving patient care - Pink of Health campaign bags Bronze in the Patient-Centric Pharmaceutical Company in Child Health category for awareness around Iron-deficiency anemia in kids
Cipla is honoured to be included in the prestigious Dow Jones Sustainability Indices (DJSI) World Index and the DJSI Emerging Markets Index for 2024. We achieved an impressive third place globally in the Drug and Pharmaceutical sector, with an ESG score of 79, up from 70 last year. This recognition underscores Cipla's steadfast commitment to sustainable growth, value creation for all stakeholders, and contributions towards a greener future. A heartfelt thank you to all our employees, partners, stakeholders, and communities for their unwavering support in reaching this milestone. Together, we are making a significant impact.
We’re Hiring! Here’s your opportunity to work at Cipla’s state-of-the-art manufacturing facility at Sikkim. Refer to the walk-in interview details below. For those unable to attend, kindly send your application to hrdskm@cipla.com
Cipla reposted this
We had an incredible experience at the ASHP Midyear Clinical Meeting & Exhibition! It was an amazing opportunity for our Cipla USA team to connect with so many inspiring healthcare professionals, partners, and innovators in New Orleans. The insights and energy we gained fuel our mission to improve healthcare together and inspire us to continue striving for excellence in everything we do. Thank you to everyone who stopped by our booth—we look forward to seeing you all again soon! #ASHP2024
Cipla reposted this
This month, we’re inviting our team to roll up their sleeves and engage in meaningful volunteer activities that truly make a difference in our communities. At Cipla, our commitment to Caring for Life goes beyond our products—it’s about building a culture of compassion and support for those around us. In December, Laura, our Senior Brand Manager, spent an afternoon volunteering at the Christmas Appeal, where she wrapped presents and packed hampers for underprivileged families across Sydney. Here’s to making a positive impact—one volunteer effort at a time! #EMEUCareMonth #CiplaAustralia #TeamCipla #energizebuildwin #CommunityEngagement #CaringForLife
Cipla reposted this
Our leaders - S. Radhakrishnan, Dr. Jaideep Gogtay, Ashish Adukia, Sneha Hiranandani, Heena Kanal, Sabeena Ladak, Dinesh Jain, Aniruddha Kunte, A N Ramesh Ramanujam, Gaurav Kaul, Ashish Vig, Anil Choudhary, Preeti S., Rahul Phalke, ANURAG MISHRA and Jayarajan Ponissery are all united to light the way! Their presence and support at our Centre's Annual Day 2024 celebrations remind us of the core values that drive Cipla's purpose of 'Caring for Life' and our 27-year commitment of making a difference to the lives of our patients and their families. Thank you for being a guiding force for all of us! #CiplaFoundation #27YearsofCPC #PalliativeCare
Cipla reposted this
MD & Global CEO | Patient Centricity I Transformation I Innovation I Digital Health | Governance
We constantly ask ourselves how we can do more to empower patients. For us at Cipla, the answer is #care and commitment to our patients. It's this care that inspires #innovation. Proud to extend our innovation portfolio to #diabetes management with this novel product. For people living with diabetes mellitus, particularly those who are averse to needles, this approach will make diabetes management easier, faster, and more convenient. Upholding our commitment to redefine patient experiences and bettering treatment adherence. #CaringForLife https://lnkd.in/eAfPs_T8
A revolutionary step in diabetes care. Cipla receives approval for distribution and marketing of inhaled insulin in India. Redefining diabetes treatment with an innovative, needle-free alternative that is tailored to meet patient needs. https://lnkd.in/dJJ7kFSV